[go: up one dir, main page]

CN111920894A - A kind of preparation method of Sanjin microcapsule preparation - Google Patents

A kind of preparation method of Sanjin microcapsule preparation Download PDF

Info

Publication number
CN111920894A
CN111920894A CN202010760963.7A CN202010760963A CN111920894A CN 111920894 A CN111920894 A CN 111920894A CN 202010760963 A CN202010760963 A CN 202010760963A CN 111920894 A CN111920894 A CN 111920894A
Authority
CN
China
Prior art keywords
sanjin
trilobal
microcapsule
powder
material liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010760963.7A
Other languages
Chinese (zh)
Inventor
黄锁义
雷智冬
李童
黄与路
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Youjiang Medical University for Nationalities
Original Assignee
Youjiang Medical University for Nationalities
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Youjiang Medical University for Nationalities filed Critical Youjiang Medical University for Nationalities
Priority to CN202010760963.7A priority Critical patent/CN111920894A/en
Publication of CN111920894A publication Critical patent/CN111920894A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738Rosa (rose)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • A61K36/12Filicopsida or Pteridopsida
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/90Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a preparation method of a Sanjin micro-capsule preparation, which comprises the steps of putting cherokee rose root, chinaroot greenbrier rhizome, sheep starter, climbing fern vine and centella into an extraction tank according to the weight ratio of 10:5:5:3:3, adding water for decoction, filtering, combining filtrates, concentrating to obtain a Sanjin extract, and drying by a pulse airflow dryer to obtain Sanjin powder; adding tea saponin, rhamnolipid, konjac glucomannan, carrageenan and Arabic gum into water according to the mass ratio of 3-5:1-3:3-5:5-10:10-20, heating and stirring uniformly to obtain capsule wall material liquid; adding the trilobal powder and the plasticizer into the capsule wall material liquid, and adding the capsule wall material liquid into a homogenizer for homogenization treatment, wherein the mass ratio of the trilobal powder to the plasticizer is 2-3:1, so as to obtain an emulsion; and adding into a spray fluidized bed for drying and granulating to obtain the Sanjin microcapsule granules. The Sanjin microcapsule preparation provided by the method can effectively realize high-efficiency encapsulation of the medicine, improve the stability of the medicine, prolong the storage period, and cover the bad smell of the Sanjin medicine, so that a patient can accept the Sanjin medicine more easily.

Description

一种三金微囊制剂的制备方法A kind of preparation method of Sanjin microcapsule preparation

技术领域technical field

本发明涉及中成药制剂技术领域,具体是一种三金微囊制剂的制备方法。The invention relates to the technical field of Chinese patent medicine preparations, in particular to a preparation method of a Sanjin microcapsule preparation.

背景技术Background technique

三金制剂是由金樱根、金刚刺(菝葜)、金沙藤、羊开口、积雪草等五味中药经过提取加工制成的中药制剂,市场上已有销售,其药理作用为:抗菌,抗炎,消肿,清热,利尿,镇痛,抗氧自由基,提高机体免疫力等。功能主治为:清热解毒,利湿通淋,益肾。用于下焦湿热、热淋,小便短赤,淋沥涩痛;急、慢性肾盂肾炎、膀胱炎、尿路感染属肾虚湿热下注证者。Sanjin preparation is a traditional Chinese medicine preparation made from five kinds of traditional Chinese medicines, such as golden cherry root, golden thorn (Smilax), golden vine, sheep opening, centella asiatica, etc., and has been sold in the market. , Swelling, heat-clearing, diuretic, analgesic, antioxidant free radicals, improve immunity, etc. Functions and indications are: clearing away heat and detoxifying, removing dampness and dredging stranguria, and benefiting the kidney. It is used for damp-heat in the lower jiao, hot stranguria, short red urination, strangulation and astringent pain; acute and chronic pyelonephritis, cystitis, urinary tract infection are those with kidney deficiency and damp-heat syndrome.

微囊化技术系利用天然或合成的高分子包囊材料(统称囊材)作为囊膜壁壳,将固态 药物或液态药物(统称芯材)包在微小、半透性或密封的囊内,从而形成药库型微型胶囊, 因其粒径在1~250μm,属微米级,故名微囊。微囊化技术使内容物在特定条件下以可控的速率释放,使药物具有控释或靶向作用。由于微囊化可以改善被包裹物质的颜色、外观、表观密度、溶解性等物理性质;提高核心物质的稳定性,改善被包裹物质的反应活性、耐久性、热敏性和光敏性,在医院领域已经得到相应的应用。Microencapsulation technology uses natural or synthetic polymer encapsulation materials (collectively referred to as capsule materials) as the capsule wall shell, and encapsulates solid drugs or liquid drugs (collectively referred to as core materials) in tiny, semi-permeable or sealed capsules. Thereby, the drug storehouse type microcapsules are formed, which are called microcapsules because their particle sizes are in the range of 1 to 250 μm and belong to the micron level. Microencapsulation technology enables the content to be released at a controlled rate under specific conditions, enabling controlled release or targeting of drugs. Because microencapsulation can improve the color, appearance, apparent density, solubility and other physical properties of the encapsulated substance; improve the stability of the core substance, improve the reactivity, durability, heat sensitivity and photosensitivity of the encapsulated substance, in the hospital field The corresponding application has been obtained.

目前市售的三金制剂药物基本为普通的糖衣片或薄膜衣片剂,根据市场销售、患者反馈意见及成品留样检验情况,片剂在贮存过程极易受潮变质,从而影响药效的发挥,也直接影响着治疗的效果。且三金片具有味道比较重的中药味道,有些消费者无法接受。At present, the commercially available Sanjin preparations are basically ordinary sugar-coated tablets or film-coated tablets. According to market sales, patient feedback and the inspection of finished product samples, the tablets are easily affected by moisture and deteriorate during storage, thus affecting the efficacy of the drug. , also directly affects the effect of treatment. And Sanjin Tablet has a strong taste of traditional Chinese medicine, which is unacceptable to some consumers.

以上背景技术内容的公开仅用于辅助理解本发明的发明构思及技术方案,其并不必然属于本专利申请的现有技术,在没有明确的证据表明上述内容在本专利申请的申请日已经公开的情况下,上述背景技术不应当用于评价本申请的新颖性和创造性。The disclosure of the above background technology content is only used to assist the understanding of the inventive concept and technical solution of the present invention, and it does not necessarily belong to the prior art of this patent application. If there is no clear evidence that the above content has been disclosed on the filing date of this patent application The above background art should not be used to evaluate the novelty and inventive step of the present application.

发明内容SUMMARY OF THE INVENTION

本发明针对现有三金普通片剂存在的不足,提供一种三金微囊制剂的制备方法。本发明方法提供的三金微囊制剂不仅可以有效实现对药品的高效包封,提高其稳定性,延长贮存期,还能掩盖三金药品的不良气味,使得患者更容易接受。Aiming at the deficiencies of existing Sanjin ordinary tablets, the invention provides a preparation method of Sanjin microcapsule preparation. The Sanjin microcapsule preparation provided by the method of the invention can not only effectively realize the high-efficiency encapsulation of the medicine, improve its stability, prolong the storage period, but also cover the bad smell of the Sanjin medicine, making it easier for patients to accept.

为了实现以上目的,本发明采用的技术方案如下:In order to achieve the above purpose, the technical scheme adopted in the present invention is as follows:

一种三金微囊制剂的制备方法,包括如下步骤:A preparation method of three gold microcapsule preparations, comprising the steps:

(1)将金樱根、菝葜、羊开口、金沙藤和积雪草按照质量比为10:5:5:3:3的重量比置于提取罐,加水煎煮,过滤,合并滤液,浓缩,得三金浸膏,再经过脉冲气流干燥机干燥,得三金粉末;(1) Put golden cherry root, sarsaparilla, sheep opening, golden vine and centella asiatica in an extraction tank according to the weight ratio of 10:5:5:3:3, add water to decoct, filter, combine the filtrate, concentrate, and obtain Sanjin extract is dried by pulse air dryer to obtain Sanjin powder;

(2)将茶皂素、鼠李糖脂、魔芋胶、卡拉胶和阿拉伯胶按照质量比为3-5:1-3:3-5:5-10:10-20加入水中,加热搅拌均匀,得囊材液;(2) Add tea saponin, rhamnolipid, konjac gum, carrageenan and gum arabic into water according to the mass ratio of 3-5:1-3:3-5:5-10:10-20, heat and stir evenly , get the capsule material liquid;

(3)将三金粉末、增塑剂及囊材液加入均质机进行均质处理,所述三金粉末和囊材液的质量比为1:2-3,得乳化液;(3) adding the three gold powder, the plasticizer and the capsule material liquid into a homogenizer for homogenization treatment, the mass ratio of the three gold powder and the capsule material liquid is 1:2-3 to obtain an emulsion;

(4)将乳化液加入至喷雾流化床进行干燥及制粒,得到三金微囊颗粒。(4) adding the emulsion to a spray fluidized bed for drying and granulation to obtain Sanjin microcapsule particles.

进一步地,所述煎煮是加入药材中药5-8倍的水,每次煎煮1.5-2.5h,煎煮2-3次。Further, the decocting is to add 5-8 times water of the medicinal materials and traditional Chinese medicines, decocting for 1.5-2.5 hours each time, and decocting 2-3 times.

进一步地,所述浓缩是在压力为-0.05 ~ -0.10Mpa、温度为60-80℃下浓缩至固含量为50-60%。Further, the concentration is to concentrate to a solid content of 50-60% at a pressure of -0.05 to -0.10Mpa and a temperature of 60-80°C.

进一步地,所述脉冲气体干燥的温度为800-100℃,风速为10-15m/s。Further, the temperature of the pulsed gas drying is 800-100°C, and the wind speed is 10-15m/s.

进一步地,所述囊材液的质量分数为25-35%。Further, the mass fraction of the capsule material liquid is 25-35%.

进一步地,所述增塑剂由蔗糖甘油脂肪酸酯、月桂酸单甘油酯和卵磷脂组成;其加入量为三金粉末质量的2-4%。Further, the plasticizer is composed of sucrose glycerol fatty acid ester, lauric acid monoglyceride and lecithin; its addition amount is 2-4% of the mass of Sanjin powder.

进一步地,所述增塑剂中蔗糖甘油脂肪酸酯、月桂酸单甘油酯和卵磷脂的质量比为1-3:1-3:3-5。Further, the mass ratio of sucrose glycerol fatty acid ester, lauric acid monoglyceride and lecithin in the plasticizer is 1-3:1-3:3-5.

进一步地,所述均质处理是在压力为40-60MPa下处理20-30min。Further, the homogenization treatment is carried out under a pressure of 40-60MPa for 20-30min.

进一步地,步骤(4)是在喷雾进风温度为40-60℃,流化床鼓风温度为60-80℃下进行干燥。Further, in step (4), drying is carried out under the temperature of the spray inlet air being 40-60°C and the blast temperature of the fluidized bed being 60-80°C.

与现有技术相比,本发明的优点及有益效果为:Compared with the prior art, the advantages and beneficial effects of the present invention are:

1、本发明方法提供的三金微囊制剂不仅可以有效实现对药品的高效包封,药品的表面致密光滑无气孔,提高其稳定性,延长贮存期,还能掩盖三金药品的不良气味,使得患者更容易接受。1. The Sanjin microcapsule preparation provided by the method of the present invention can not only effectively realize the efficient encapsulation of the medicine, the surface of the medicine is dense and smooth without pores, improve its stability, prolong the storage period, and can also cover the bad smell of the Sanjin medicine, make it easier for patients to accept.

2、本方法以茶皂素、鼠李糖脂、魔芋胶、卡拉胶和阿拉伯胶作为壁材材料,不仅提高微囊的致密性,更易将三金药品进行包封,微囊产品性质更加稳定且掩盖了药品的不良气味。2. This method uses tea saponin, rhamnolipid, konjac gum, carrageenan and gum arabic as the wall material, which not only improves the compactness of the microcapsules, but also makes it easier to encapsulate the three gold medicines, and the properties of the microcapsule products are more stable And cover up the bad smell of medicines.

3、本方法利用脉冲气流干燥机对三金干膏粉进行干燥,受热均匀,干燥时间段效率提高,干燥过程中有利于三金粉末的分散。3. The method uses a pulse air dryer to dry the Sanjin dry paste powder, which is heated evenly, and the drying efficiency is improved, which is beneficial to the dispersion of the Sanjin powder in the drying process.

4、本发明方法还加入蔗糖甘油脂肪酸酯、月桂酸单甘油酯和卵磷脂组成的增塑剂,提高均质过程中的流动性,使三金粉末与壁材能够更好的结合,提高壁材对三金粉末的包封效果,制得的微囊表面更加致密光滑,无气孔,药品的稳定性提高。4. The method of the present invention also adds a plasticizer composed of sucrose glycerol fatty acid ester, lauric acid monoglyceride and lecithin to improve the fluidity during the homogenization process, so that the three gold powder can be better combined with the wall material, and the The encapsulation effect of the wall material on the three gold powders makes the surface of the prepared microcapsules more dense and smooth, without pores, and the stability of the medicine is improved.

具体实施方式Detailed ways

下面结合具体实施方式对本发明作进一步详细说明。应该强调的是,下述说明仅仅是示例性的,而不是为了限制本发明的范围及其应用。The present invention will be further described in detail below in conjunction with specific embodiments. It should be emphasized that the following description is exemplary only, and is not intended to limit the scope of the invention and its application.

实施例1Example 1

一种三金微囊制剂的制备方法,包括如下步骤:A preparation method of three gold microcapsule preparations, comprising the steps:

(1)将金樱根、菝葜、羊开口、金沙藤和积雪草按照质量比为10:5:5:3:3的重量比置于提取罐,加药材重量6倍的水煎煮3次,每次煎煮2h,过滤,合并滤液,在压力为-0.06Mpa、温度为75℃下浓缩至固含量为55%,得三金浸膏,再经过脉冲气流干燥机在温度为80℃,风速为15m/s下干燥,得三金粉末;(1) Put golden cherry root, sarsaparilla, sheep opening, golden vine and centella asiatica in the extraction tank according to the weight ratio of 10:5:5:3:3, add 6 times the weight of the medicinal materials and decoct 3 times, Decoct for 2h each time, filter, combine the filtrate, concentrate to 55% solid content at a pressure of -0.06Mpa and a temperature of 75°C to obtain Sanjin extract, which is then passed through a pulse air dryer at a temperature of 80°C and a wind speed of 80°C. Dry at 15m/s to obtain three gold powders;

(2)将茶皂素、鼠李糖脂、魔芋胶、卡拉胶和阿拉伯胶按照质量比为4:3:5:8:12加入水中,配成质量分数为32%的溶液,加热搅拌均匀,得囊材液;(2) Add tea saponin, rhamnolipid, konjac gum, carrageenan and gum arabic into water according to the mass ratio of 4:3:5:8:12 to form a solution with a mass fraction of 32%, heat and stir evenly , get the capsule material liquid;

(3)将三金粉末、增塑剂及囊材液加入均质机,在压力为50MPa下进行均质处理30min,所述三金粉末和囊材液的质量比为1:2,所述增塑剂由质量比为2:3:5蔗糖甘油脂肪酸酯、月桂酸单甘油酯和卵磷脂组成;其加入量为三金粉末质量的3.6%,得乳化液;(3) Add the three gold powder, plasticizer and capsule material liquid into the homogenizer, and carry out homogenization treatment under the pressure of 50MPa for 30 minutes. The mass ratio of the three gold powder and the capsule material liquid is 1:2. The plasticizer is composed of sucrose glycerol fatty acid ester, lauric acid monoglyceride and lecithin in a mass ratio of 2:3:5; its addition amount is 3.6% of the mass of Sanjin powder to obtain an emulsion;

(4)将乳化液加入至喷雾流化床进行干燥及制粒,所述干燥是在喷雾进风温度为50℃,流化床鼓风温度为70℃下进行干燥,得到粒径为80目的三金微囊颗粒。(4) The emulsion is added to the spray fluidized bed for drying and granulation. The drying is carried out at a spray air inlet temperature of 50°C and a fluidized bed blast temperature of 70°C to obtain a particle size of 80 meshes. Sanjin microcapsule particles.

实施例2Example 2

一种三金微囊制剂的制备方法,包括如下步骤:A preparation method of three gold microcapsule preparations, comprising the steps:

(1)将金樱根、菝葜、羊开口、金沙藤和积雪草按照质量比为10:5:5:3:3的重量比置于提取罐,加药材重量7倍的水煎煮2次,每次煎煮2.5h,过滤,合并滤液,在压力为-0.08Mpa、温度为65℃下浓缩至固含量为50%,得三金浸膏,再经过脉冲气流干燥机在温度为100℃,风速为15m/s下干燥,得三金粉末;(1) Put golden cherry root, sarsaparilla, sheep opening, golden vine and centella asiatica in the extraction tank according to the weight ratio of 10:5:5:3:3, add 7 times the weight of medicinal materials and decoct for 2 times, Decoct for 2.5h each time, filter, combine the filtrate, concentrate to 50% solid content at a pressure of -0.08Mpa and a temperature of 65°C to obtain Sanjin extract, which is then passed through a pulse air dryer at a temperature of 100°C, Dry at a wind speed of 15m/s to obtain three gold powders;

(2)将茶皂素、鼠李糖脂、魔芋胶、卡拉胶和阿拉伯胶按照质量比为3:2:4:7:15加入水中,配成质量分数为28%的溶液,加热搅拌均匀,得囊材液;(2) Add tea saponin, rhamnolipid, konjac gum, carrageenan and gum arabic into water according to the mass ratio of 3:2:4:7:15 to form a solution with a mass fraction of 28%, heat and stir evenly , get the capsule material liquid;

(3)将三金粉末、增塑剂及囊材液加入均质机,在压力为60MPa下进行均质处理25min,所述三金粉末和囊材液的质量比为1:2.5,所述增塑剂由质量比为1:2:4蔗糖甘油脂肪酸酯、月桂酸单甘油酯和卵磷脂组成;其加入量为三金粉末质量的2.8%,得乳化液;(3) Add the three gold powder, plasticizer and capsule material liquid into the homogenizer, and carry out homogenization treatment under the pressure of 60MPa for 25 minutes. The mass ratio of the three gold powder and the capsule material liquid is 1:2.5. The plasticizer is composed of 1:2:4 mass ratio of sucrose glycerol fatty acid ester, lauric acid monoglyceride and lecithin; its addition amount is 2.8% of the mass of Sanjin powder to obtain an emulsion;

(4)将乳化液加入至喷雾流化床进行干燥及制粒,所述干燥是在喷雾进风温度为60℃,流化床鼓风温度为80℃下进行干燥,得到粒径为60目的三金微囊颗粒。(4) The emulsion is added to the spray fluidized bed for drying and granulation. The drying is carried out at a spray air inlet temperature of 60°C and a fluidized bed blast temperature of 80°C to obtain a particle size of 60 meshes. Sanjin microcapsule particles.

实施例3Example 3

一种三金微囊制剂的制备方法,包括如下步骤:A preparation method of three gold microcapsule preparations, comprising the steps:

(1)将金樱根、菝葜、羊开口、金沙藤和积雪草按照质量比为10:5:5:3:3的重量比置于提取罐,加药材重量5倍的水煎煮3次,每次煎煮2h,过滤,合并滤液,在压力为-0.08Mpa、温度为70℃下浓缩至固含量为50%,得三金浸膏,再经过脉冲气流干燥机在温度为90℃,风速为12m/s下干燥,得三金粉末;(1) Put golden cherry root, sarsaparilla, sheep opening, golden vine and centella asiatica in the extraction tank according to the weight ratio of 10:5:5:3:3, add 5 times the weight of medicinal materials and decoct 3 times, Decoct for 2h each time, filter, combine the filtrate, concentrate to 50% solid content at a pressure of -0.08Mpa and a temperature of 70°C to obtain Sanjin extract, which is then passed through a pulse air dryer at a temperature of 90°C and a wind speed of 90°C. Dry at 12m/s to obtain three gold powders;

(2)将茶皂素、鼠李糖脂、魔芋胶、卡拉胶和阿拉伯胶按照质量比为5:2:3:8:12加入水中,配成质量分数为28%的溶液,加热搅拌均匀,得囊材液;(2) Add tea saponin, rhamnolipid, konjac gum, carrageenan and gum arabic into water in a mass ratio of 5:2:3:8:12 to form a solution with a mass fraction of 28%, heat and stir evenly , get the capsule material liquid;

(3)将三金粉末、增塑剂及囊材液加入均质机,在压力为50MPa下进行均质处理25min,所述三金粉末和囊材液的质量比为1:3,所述增塑剂由质量比为3:2:5蔗糖甘油脂肪酸酯、月桂酸单甘油酯和卵磷脂组成;其加入量为三金粉末质量的3.0%,得乳化液;(3) Add the three gold powder, plasticizer and capsule material liquid into the homogenizer, and carry out homogenization treatment under the pressure of 50MPa for 25 minutes. The mass ratio of the three gold powder and the capsule material liquid is 1:3. The plasticizer is composed of 3:2:5 mass ratio of sucrose glycerol fatty acid ester, lauric acid monoglyceride and lecithin; its addition amount is 3.0% of the mass of Sanjin powder to obtain an emulsion;

(4)将乳化液加入至喷雾流化床进行干燥及制粒,所述干燥是在喷雾进风温度为60℃,流化床鼓风温度为70℃下进行干燥,得到粒径为100目的三金微囊颗粒。(4) The emulsion is added to the spray fluidized bed for drying and granulation. The drying is carried out at a spray air inlet temperature of 60°C and a fluidized bed blast temperature of 70°C to obtain a particle size of 100 mesh. Sanjin microcapsule particles.

实施例4Example 4

一种三金微囊制剂的制备方法,包括如下步骤:A preparation method of three gold microcapsule preparations, comprising the steps:

(1)将金樱根、菝葜、羊开口、金沙藤和积雪草按照质量比为10:5:5:3:3的重量比置于提取罐,加药材重量7倍的水煎煮3次,每次煎煮2h,过滤,合并滤液,在压力为-0.10Mpa、温度为60℃下浓缩至固含量为50%,得三金浸膏,再经过脉冲气流干燥机在温度为100℃,风速为10m/s下干燥,得三金粉末;(1) Put golden cherry root, sarsaparilla, sheep opening, golden vine and centella asiatica in the extraction tank according to the weight ratio of 10:5:5:3:3, add 7 times the weight of medicinal materials and decoct 3 times, Decoct for 2 hours each time, filter, combine the filtrate, concentrate to 50% solid content at a pressure of -0.10Mpa and a temperature of 60°C to obtain Sanjin extract, which is then passed through a pulse air dryer at a temperature of 100°C and a wind speed of 100°C. Dry at 10m/s to obtain three gold powders;

(2)将茶皂素、鼠李糖脂、魔芋胶、卡拉胶和阿拉伯胶按照质量比为4:2:4:6:18加入水中,配成质量分数为28%的溶液,加热搅拌均匀,得囊材液;(2) Add tea saponin, rhamnolipid, konjac gum, carrageenan and gum arabic into water according to the mass ratio of 4:2:4:6:18 to form a solution with a mass fraction of 28%, heat and stir evenly , get the capsule material liquid;

(3)将三金粉末、增塑剂及囊材液加入均质机,在压力为60MPa下进行均质处理20min,所述三金粉末和囊材液的质量比为1:3,所述增塑剂由质量比为3:2:4蔗糖甘油脂肪酸酯、月桂酸单甘油酯和卵磷脂组成;其加入量为三金粉末质量的2.7%,得乳化液;(3) Add the three gold powder, plasticizer and capsule material liquid into the homogenizer, and carry out homogenization treatment under the pressure of 60MPa for 20 minutes. The mass ratio of the three gold powder and the capsule material liquid is 1:3. The plasticizer is composed of 3:2:4 sucrose glycerol fatty acid ester, lauric acid monoglyceride and lecithin in mass ratio; its addition amount is 2.7% of the mass of Sanjin powder to obtain an emulsion;

(4)将乳化液加入至喷雾流化床进行干燥及制粒,所述干燥是在喷雾进风温度为40℃,流化床鼓风温度为60℃下进行干燥,得到粒径为80目的三金微囊颗粒。(4) The emulsion is added to the spray fluidized bed for drying and granulation. The drying is carried out at a spray air inlet temperature of 40°C and a fluidized bed blast temperature of 60°C to obtain a particle size of 80 meshes. Sanjin microcapsule particles.

实施例5Example 5

一种三金微囊制剂的制备方法,包括如下步骤:A preparation method of three gold microcapsule preparations, comprising the steps:

(1)将金樱根、菝葜、羊开口、金沙藤和积雪草按照质量比为10:5:5:3:3的重量比置于提取罐,加药材重量8倍的水煎煮2次,每次煎煮2.5h,过滤,合并滤液,在压力为-0.08Mpa、温度为65℃下浓缩至固含量为60%,得三金浸膏,再经过脉冲气流干燥机在温度为100℃,风速为12m/s下干燥,得三金粉末;(1) Put golden cherry root, sarsaparilla, sheep opening, golden vine and centella asiatica in the extraction tank according to the weight ratio of 10:5:5:3:3, add 8 times the weight of the medicinal materials and decoct for 2 times, Decoct for 2.5 hours each time, filter, combine the filtrate, concentrate to 60% solid content at a pressure of -0.08Mpa and a temperature of 65°C to obtain Sanjin extract, which is then passed through a pulse air dryer at a temperature of 100°C, Dry at a wind speed of 12m/s to obtain three gold powders;

(2)将茶皂素、鼠李糖脂、魔芋胶、卡拉胶和阿拉伯胶按照质量比为5:2:3:7:13加入水中,配成质量分数为30%的溶液,加热搅拌均匀,得囊材液;(2) Add tea saponin, rhamnolipid, konjac gum, carrageenan and gum arabic into water according to the mass ratio of 5:2:3:7:13 to form a solution with a mass fraction of 30%, heat and stir evenly , get the capsule material liquid;

(3)将三金粉末、增塑剂及囊材液加入均质机,在压力为40MPa下进行均质处理25min,所述三金粉末和囊材液的质量比为1:3,所述增塑剂由质量比为3:3:4蔗糖甘油脂肪酸酯、月桂酸单甘油酯和卵磷脂组成;其加入量为三金粉末质量的3.5%,得乳化液;(3) Add the three gold powder, plasticizer and capsule material liquid into the homogenizer, and carry out homogenization treatment under the pressure of 40MPa for 25 minutes. The mass ratio of the three gold powder and the capsule material liquid is 1:3. The plasticizer is composed of 3:3:4 mass ratio of sucrose glycerol fatty acid ester, lauric acid monoglyceride and lecithin; its addition amount is 3.5% of the mass of Sanjin powder to obtain an emulsion;

(4)将乳化液加入至喷雾流化床进行干燥及制粒,所述干燥是在喷雾进风温度为40℃,流化床鼓风温度为80℃下进行干燥,得到粒径为60目的三金微囊颗粒。(4) The emulsion is added to the spray fluidized bed for drying and granulation. The drying is carried out at a spray air inlet temperature of 40°C and a fluidized bed blast temperature of 80°C to obtain a particle size of 60 meshes. Sanjin microcapsule particles.

将本实施例1-5按照常规方法测定三金微囊颗粒包封率及稳定性能,其中包封率=微囊中包封的积雪草苷的质量/微囊中包封与未包封的积雪草苷的总量×100%,产品含量保留率计算条件为:25℃、RH75%下抽样测定,测定结果如表1所示。The encapsulation efficiency and stability of Sanjin microcapsule particles were measured according to conventional methods in Examples 1-5, wherein the encapsulation efficiency=mass of asiaticoside encapsulated in the microcapsule/encapsulated and unencapsulated in the microcapsule The total amount of asiaticoside × 100%, the calculation conditions for the retention rate of the product content are: 25 ℃, RH75% sampling measurement, the measurement results are shown in Table 1.

表1:本发明三金微囊制剂产品的包封率及稳定性测定结果Table 1: Encapsulation efficiency and stability measurement results of three gold microcapsule preparation products of the present invention

Figure 770134DEST_PATH_IMAGE001
Figure 770134DEST_PATH_IMAGE001

从上述测试结果得知,本发明制得的三金微囊制剂具有很好的包封率和产品稳定性。It can be known from the above test results that the three gold microcapsule preparation prepared by the present invention has good encapsulation efficiency and product stability.

以上内容是结合具体的/优选的实施方式对本发明所作的进一步详细说明,不能认定本发明的具体实施只局限于这些说明。对于本发明所属技术领域的普通技术人员来说,在不脱离本发明构思的前提下,其还可以对这些已描述的实施例做出若干替代或变型,而这些替代或变型方式都应视为属于本发明的保护范围。The above content is a further detailed description of the present invention in conjunction with specific/preferred embodiments, and it cannot be considered that the specific implementation of the present invention is limited to these descriptions. For those skilled in the art to which the present invention pertains, without departing from the concept of the present invention, they can also make several substitutions or modifications to the described embodiments, and these substitutions or modifications should be regarded as It belongs to the protection scope of the present invention.

Claims (9)

1. A preparation method of a three-gold microcapsule preparation is characterized by comprising the following steps: the method comprises the following steps:
(1) placing cherokee rose root, chinaroot greenbrier, Yangkou, sargentgloryvine stem and centella asiatica in an extraction tank according to the weight ratio of 10:5:5:3:3, adding water for decoction, filtering, combining filtrates, concentrating to obtain Sanjin extract, and drying by a pulse airflow dryer to obtain Sanjin powder;
(2) adding tea saponin, rhamnolipid, konjac glucomannan, carrageenan and Arabic gum into water according to the mass ratio of 3-5:1-3:3-5:5-10:10-20, heating and stirring uniformly to obtain capsule wall material liquid;
(3) adding the Trigold powder, the plasticizer and the capsule wall material liquid into a homogenizer for homogenization treatment, wherein the mass ratio of the Trigold powder to the capsule wall material liquid is 1:2-3, and obtaining an emulsion;
(4) and adding the emulsion into a spray fluidized bed for drying and granulating to obtain the gold microcapsule particles.
2. The method for preparing a trilobal microcapsule formulation according to claim 1, wherein: the decoction is carried out by adding 5-8 times of water into the raw materials, and decocting for 1.5-2.5h and 2-3 times each time.
3. The method for preparing a trilobal microcapsule formulation according to claim 1, wherein: the concentration is carried out under the pressure of-0.05 to-0.10 Mpa and the temperature of 60 to 80 ℃ until the solid content is 50 to 60 percent.
4. The method for preparing a trilobal microcapsule formulation according to claim 1, wherein: the drying temperature of the pulse gas is 80-100 ℃, and the wind speed is 10-15 m/s.
5. The method for preparing a trilobal microcapsule formulation according to claim 1, wherein: the mass fraction of the capsule wall material liquid is 25-35%.
6. The method for preparing a trilobal microcapsule formulation according to claim 1, wherein: the plasticizer consists of sucrose glycerin fatty acid ester, lauric acid monoglyceride and lecithin; the addition amount is 2-4% of the weight of the three-gold powder.
7. The method for preparing a trilobal microcapsule formulation according to claim 6, wherein: the mass ratio of the sucrose glycerin fatty acid ester to the lauric acid monoglyceride to the lecithin in the plasticizer is 1-3:1-3: 3-5.
8. The method for preparing a trilobal microcapsule formulation according to claim 1, wherein: the homogenizing treatment is carried out under 40-60MPa for 20-30 min.
9. The method for preparing a trilobal microcapsule formulation according to claim 1, wherein: and (4) drying at the air inlet spraying temperature of 40-60 ℃ and the air blowing temperature of the fluidized bed of 60-80 ℃.
CN202010760963.7A 2020-07-31 2020-07-31 A kind of preparation method of Sanjin microcapsule preparation Pending CN111920894A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010760963.7A CN111920894A (en) 2020-07-31 2020-07-31 A kind of preparation method of Sanjin microcapsule preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010760963.7A CN111920894A (en) 2020-07-31 2020-07-31 A kind of preparation method of Sanjin microcapsule preparation

Publications (1)

Publication Number Publication Date
CN111920894A true CN111920894A (en) 2020-11-13

Family

ID=73315075

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010760963.7A Pending CN111920894A (en) 2020-07-31 2020-07-31 A kind of preparation method of Sanjin microcapsule preparation

Country Status (1)

Country Link
CN (1) CN111920894A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1733272A (en) * 2004-08-13 2006-02-15 贵阳云岩西创药物科技开发有限公司 Pulean pharmaceutical preparation for treating urinary system diseases and process for preparing the same
CN106262926A (en) * 2016-08-11 2017-01-04 晨光生物科技集团股份有限公司 A kind of Lutein ester microcapsule preparation and its production and use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1733272A (en) * 2004-08-13 2006-02-15 贵阳云岩西创药物科技开发有限公司 Pulean pharmaceutical preparation for treating urinary system diseases and process for preparing the same
CN106262926A (en) * 2016-08-11 2017-01-04 晨光生物科技集团股份有限公司 A kind of Lutein ester microcapsule preparation and its production and use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
本书编委会: "《药学专业知识 1 第7版 2017版》", 31 January 2017 *

Similar Documents

Publication Publication Date Title
WO2013191319A1 (en) Method for preparing granule or pill containing extract in high concentration
CN104906046A (en) Method covering traditional Chinese medicine particle fishy smell
CN108836950A (en) A kind of albumen sporopollenin takes orally the preparation method of microcapsules
JP2020518596A (en) Chinese herbal medicine extract effective for depression, its preparation method and use
CN103610659B (en) A kind of Allicin medicinal composition and preparation method thereof
CN111607014A (en) A kind of preparation method of glycyrrhizin polysaccharide iron chelate
CN100386103C (en) Plaster for relieving asthma and stopping cough and its preparation method
CN102940824B (en) Traditional Chinese medicine composition for treating nephritis as well as preparation method and application of composition
CN102940846B (en) Traditional Chinese medicine composition for treating atrophic gastritis as welln as preparation method and application of composition
CN106362126A (en) Preparation method of brewing tea tablet for treating common cold due to wind cold
CN106036829B (en) A kind of compound mature vinegar micro-capsule and the preparation method and application thereof
WO2021184639A1 (en) Microcapsule preparation for eliminating food stagnation and relieving coughs in children and preparation method therefor
CN102266452A (en) Chinese medicinal composition for enhancing anoxia endurance and preparation method and application thereof
CN101524404B (en) A kind of intestinal sustained-release controlled-release capsule
CN108434119B (en) A kind of preparation method of protein oral microcapsule preparation
CN111920894A (en) A kind of preparation method of Sanjin microcapsule preparation
CN102266293B (en) Ambroxol hydrochloride sustained-release dry suspension and preparation method thereof
CN101209341B (en) Chinese medicinal preparation, preparation and detection method thereof
CN101366939A (en) Compound traditional Chinese medicine Xintongling nano-microcapsules and its preparation
CN110876736A (en) A kind of astragalus polysaccharide capsule shell and preparation method thereof
CN113827570B (en) Method for preparing traditional Chinese medicine pellet preparation based on drug carrier technology and application thereof
CN112220859B (en) Preparation process of compound traditional Chinese medicine preparation
CN111821367A (en) A kind of method for preparing Pinellia dew microcapsule granules
CN111973658A (en) Preparation process of compound honeysuckle microcapsules
CN102940845B (en) Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20201113